The long-term effects of heart failure (HF) in patients with Type 2 diabetes (T2D) emphasizes the global prevalence of heart failure and its impact on hospitalization rates, mortality outcomes, and quality of life. The importance of risk stratification and early intervention is emphasized, along with the potential benefits of SGLT2 inhibitors in reducing heart failure hospitalizations and improving cardiovascular outcomes.